The Neuroscience of the Sacrament

5-HT₂A agonism, synergistic MAO inhibition, and Default Mode Network (DMN) modulation.

Neurogenesis & Structural Plasticity (BDNF Modulation)

Preclinical and cellular models (including research led by Dr. Draulio de Araujo and international neuroscientists) reveal that harmala alkaloids and DMT stimulate the expression of Brain-Derived Neurotrophic Factor (BDNF) and Glial Cell Line-Derived Neurotrophic Factor (GDNF). Studies on cortical neurons show increased dendritic spine density, dendritic arborization, and synaptic re-wiring following exposure to these alkaloids, confirming that Ayahuasca does not merely evoke transient imagery—it re-opens a critical window of neuroplastic receptivity for behavioral transformation.

Clinical Psychiatric Research & Mental Health

Double-blind, randomized controlled trials on treatment-resistant depression, PTSD, and addiction.

Safety Epidemiology & Refutation of Administrative Claims

Cross-system AI analytics, computational epidemiology, and large-cohort data sets.

Refutation of Flawed Administrative Assertions

In federal FOIA disclosures, enforcement agencies have asserted that “adverse health effects... and lack of standardized definitions... lead to the only logical conclusion: Ayahuasca is not safe and is a threat to human health.” Contemporary clinical science, computational modeling, and judicial findings directly falsify this sweeping conclusion:

The Physiological Purge vs. Medical Toxicity

Ayahuasca administration transiently stimulates peripheral serotonin receptors in the gut, producing nausea, vomiting, and diarrhea. While non-practitioners may confuse vomiting with accidental poisoning, clinical pharmacologists categorize this somatic purgation (la purga) as a self-limiting, transient physiological response. Ayahuasca produces moderate, temporary elevations in blood pressure and pulse comparable to moderate cardiovascular exercise (Dos Santos et al., 2016), confirming that when dangerous pharmaceutical contraindications (such as SSRIs or unmanaged hypertension) are eliminated through strict screening, the brew displays an exceptional profile of somatic safety.

Connected Research Network (Citation Graph)

Visualizing co-citation density and foundational clinical clusters around Ayahuasca science.

This conceptual citation graph illustrates the primary interconnected research hubs defining modern Ayahuasca literature. Inspired by scientific discovery engines (such as Connected Papers), this network highlights how foundational pharmacological papers bridge directly into psychiatric medicine, neuroimaging, and safety epidemiology.

Historical Antiquity & Indigenous Stewardship

Archeological evidence, indigenous diversity, and the cultural context of healing.

The contemporary medical model frequently makes the error of isolating molecules from their cultural, intentional, and ethical matrix. Ethnobotanical field research across the Upper Amazon confirms that Ayahuasca is fundamentally an ancestral healing technology:

• Millennia of Documented Practice: Archeological investigations in the Bolivian Andes and Amazonian river basins confirm entheogenic residue and ceremonial snuff paraphenalia dating back at least 1,000 to 2,000 years.
• Tribal Biodiversity: Of the more than 400 distinct indigenous groups living within the Amazon Basin, an estimated 10% to 15% possess unbroken historical lineages with Ayahuasca or Yagé (including the Yawanawá, Ashaninka, Huni Kuin, Shipibo-Conibo, Urarina, and Witoto peoples).
• The Traditional Screening Mechanism: Indigenous lineages have always exercised rigorous screening: restricting communion to prepared adults, observing strict dietary purifications (dietas), and anchoring visionary navigation inside the acoustic architecture of icaros and prayers.

At Ayahuasca Community Fellowship, our ministry bridges this rigorous scientific literacy with uncompromised ancestral reverence.